Effect of umbilical vein oxytocin on puerperal blood loss and length of the third stage of labor

The use of umbilical vein injection of oxytocin was compared with traditional management of the third stage of labor. Pregnant women were randomized to receive intravenous oxytocin after the delivery of the placenta (n = 25) or oxytocin via the umbilical vein immediately after cord clamping (n = 25)...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of obstetrics and gynecology Vol. 160; no. 1; p. 206
Main Authors Reddy, V V, Carey, J C
Format Journal Article
LanguageEnglish
Published United States 01.01.1989
Subjects
Female
Hematocrit
Humans
Injections, Intravenous
Labor Stage, Third - drug effects
Labor, Obstetric - drug effects
Oxytocin - administration & dosage
Oxytocin - pharmacology
Oxytocin - therapeutic use
Postpartum Hemorrhage - prevention & control
Pregnancy
Umbilical Veins
Online AccessGet more information

Cover

More Information
Summary:The use of umbilical vein injection of oxytocin was compared with traditional management of the third stage of labor. Pregnant women were randomized to receive intravenous oxytocin after the delivery of the placenta (n = 25) or oxytocin via the umbilical vein immediately after cord clamping (n = 25). Those who received umbilical vein oxytocin had a shorter third stage of labor (4.1 versus 9.4 minutes), less measured blood loss (135 versus 373 ml), and a lower drop in hematocrit (3.9% versus 6.2%). Intraumbilical vein oxytocin appears to be a useful alternative to traditional management of the third stage of labor.
ISSN:0002-9378
DOI:10.1016/0002-9378(89)90122-1